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Dear Editor:
Behçet’s disease (BD) is a systemic inflammatory disorder 
characterized by recurrent oral ulcers, genital ulcers, 
uveitis, and skin lesions
1. Involvement of other organs 
such as gastrointestinal (GI) tract, central nervous system 
(CNS) or large vessels is less frequent. Among these 
systemic involvements of BD, GI involvement is relatively 
common; it occurs in approximately 10∼30% of East-Asian 
BD patients
2-4. Neuro-Behçet’s disease (NBD) is relatively 
rare; the prevalence was about 5% in a large Korean 
epidemiologic study
5,6. Due to the low prevalence and 
lack of large controlled studies, the clinical course and the 
presence of other organ involvement in patients with NBD 
is yet to be confirmed. Herein we report a rare case of 
simultaneous involvement of nervous and GI systems in a 
young female patient with BD. A 34-year-old woman with 
recurrent orogenital ulcers had been visiting outpatient 
clinics regularly since March 2007. Three months later, 
she complained of severe lower abdominal pain. Colo-
noscopic examination revealed a deep ulcer on the 
ileocecal valve, and administration of oral corticosteroids 
and sulfasalzaine was started on the suspicion of Behçet’s 
colitis. Within one month of the medication, she addi-
tionally complained of left hemiparesis and facial palsy, 
dysarthria, and diplopia in spite of steroid treatment, and 
she was referred to our clinic. Brain magnetic resonance 
imaging showed a small acute infarction at the right 
central area of the midbrain and upper pons (Fig. 1). The 
characteristic location of the infarction without evidence 
of other demyelinating diseases and the typical clinical 
manifestations lead to the diagnosis of NBD, with the 
coexistence of Behçet’s colitis. Since then, regular 
medication (prednisolone 10 mg/day) was taken over a 
3-year follow up and then withdrawn. During the 
follow-up period, there was no evidence of disease 
progression though sequelae of NBD were observed. 
However, in October 2010, she presented with a 1-day 
history of lower abdominal pain and fever. Abdominal 
computed tomography studies revealed an ulcerative 
lesion in the terminal ileum (Fig. 2A). On emergency 
bowel resection, a 1 cm-sized ulceration was found 
around the ileocecal valve. Microscopically, the specimen 
showed chronic perforating enterocolitis with multiple 
ulcerations, consistent with recurrent Behçet’s colitis (Fig. 
2B). Oral corticosteroid (prednisolone 30 mg/day) was 
administrated for 10 days and tapered to 10 mg/day as 
maintenance therapy for 3 months. After a 5-month 
follow-up period, she remains stable with steroid- free 
therapy at present. 
There are addressable issues in our case. First, the patient 
with BD had simultaneous onset of active ileal ulceration 
and acute neurologic deficits, which is known to be very 
rare
7,8. However, she had suffered from Behçet’s colitis 
since 1999 and the neurologic events followed 5 years 
later. Second, both systemic involvements of BD developed 
almost immediately following the initial diagnosis in this 
case. It was previously reported that both CNS and GI 
involvement in BD usually develops later in most cases - 
on average 4 years and 2 years after diagnosis, res-JY Lee, et al
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Fig. 1. Axial brain magnetic resonance
imaging revealed a hyperintense 
lesion in the right central area of the 
mesodiencephalic junction on a 
T2-weighted image (A: midbrain, B: 
upper pons) and a fluid- attenuated 
inversion-recovery sequence (C: mid-
brain, D: upper pons). These findings
suggested that a small infarction had
occurred (arrows).
Fig. 2. (A) Abdominal computed tomography study revealed an ulcerative lesion in the terminal ileum (arrows). (B) The specimen 
from ileocecal resection revealed perforating enterocolitis with multiple ulceration, lymphoid aggregates, and fibrosis, consistent with
Behçet’s colitis (original magnification, H&E, ×10).
pectively
9,10. In accordance with that report, there has 
been only one additional case, a 60-year-old woman, in 
our clinic who have had both CNS and GI involvement 
(data not shown). Third, NBD is known to be more 
frequent in males; however, both this case and the 
additional case of the 60-year-old woman were female. 
Generally, eye and CNS involvement are more frequent in 
males, while genital ulcers and arthritis are more frequent Neuro-Gastrointestinal Behçet’s Disease
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in females
9. Finally, despite proper steroid treatment for 
Behçet’s colitis, a new onset of CNS involvement and 
recurrence of ileocecal ulcer developed in our case. 
Recently it was reported that a large deep ulcer may 
contribute to a refractory clinical course and a poor 
prognosis for patients with Behçet’s colitis
11. Our patient 
had about a 1 cm-sized deep ulcer, which could have 
contributed to the aggressive nature of the disease. In 
addition, there have been two case reports of acute 
neurologic deficits in BD patients who had a consequent 
active ileocecal ulcer in spite of steroid pulse therapy
7,12. It 
seems that systemic steroid treatment may not be enough 
to control acute and severe systemic involvement in BD. 
Although the causes of the aggressive and refractory 
course of disease were not clearly demonstrated, genetic 
polymorphisms such as in the matrix metalloproteinases 
(MMPs) gene might affect clinical and therapeutic out-
comes in BD
13. Homozygotes of MMP-9 (MMP9-1562*C/ 
*C), a novel susceptibility gene, and which might affect 
the natural course of BD, was also found in our case (data 
not shown). In conclusion, we experienced a rare case of 
simultaneous involvement of nervous and GI systems in 
refractory BD. Further studies of genetic polymorphisms of 
other candidate genes may clarify the individual 
differences in therapeutic outcomes and disease courses of 
BD.
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